Archive for the ‘MYELOGENOUS LEUKEMIA’ Category
Acute Myelogenous Leukemia, which is also known as AML, is a life taking disease. Actually it’s a cancer , a rapid-growing cancer regarding bone marrow and blood. Blasts are made by bone marrow in AML. Blasts contain numerous unformed cells which develop into white blood cells, those blood cells which are engaged in attacking infections. In AML, these Blasts are abnormal which means that they are not developed properly and they don’t have the ability to fight infections.
There are high chances in AML that abnormal red blood cells and platelets may also develop. These leukemia cells (abnormal cells) grow very fast and the normal blood cells needed by the body are crowded out by these leukemia cells. AML is mostly found in adults who are older than 50 years and its incidence increases as the age increases. Although this disease is usually proved to be a deadly one but it still has some surviving cases. AML survival rate is 40 percent according to the survey of last five years.
AML is not much found in children but in adults it is commonly found in men rather than women. Treatment of AML is done through chemotherapy. The main purpose of induction chemotherapy is to try to bring the disease into a state where the patient’s blood count comes to normal and no sign of disease is shown by the samples of bone marrow.
AML survival rate of 40 percent is also common to subtypes of AML that includes:
• Acute Promyelocytic Leukemia.
• Acute Myeloblastic Leukemia.
• Acute Megakaryoblastic Leukemia.
The AML survival rate of 40 percent is bit low. If science works more towards AML then most probably AML survival rate will increase than 40 percent.